- CA 125 (Ovarian Cancer Marker) (1)
- CA125 (Ovarian CANCER MARKER)
- CA 15.3 (Breast Cancer Marker) (1)
- Ca 15.3
- Carcinoembryonic Antigen (CEA). (1)
- CEA
- Complete Blood Count (CBC) (26)
- Absolute Basophils Count, Blood
- Absolute Eosinophil Count, Blood
- Absolute Lymphocyte Count, Blood
- Absolute Monocyte Count, Blood
- Absolute Neutrophil Count, Blood
- Basophils
- Eosinophils
- Hemoglobin Hb
- Lymphocytes
- MCH
- MCHC
- MCV
- MENTZER INDEX9MCV/RCC
- Monocytes
- MPV Mean Platelet Volume
- Neutrophils
- PCT
- PCV Haematocrit
- PDW Platelet Distribution Width
- Platelet Count Thrombocyte count
- P – LCC
- P – LCR
- RBC Count
- RDW-CV
- RDW (Red Cell Distribution Width)
- WBC-Total Counts Leucocytes
- Human Chorionic Gonodotropin (HCG), Tumor Marker (1)
- HCG (Required HCG BETA, TUMOR MARKER)
The “Cancer Advance Package- Female” provided by Redcliffelabs is designed to offer a comprehensive assessment of cancer-related markers specifically for females. This package includes 30 blood tests that cover various cancer-related markers
Benefits of Cancer Advance Package- Female:
- Cancer Detection: The package includes markers like CA 125 (associated with ovarian cancer), CA 15.3 (associated with breast cancer), and CEA (carcinoembryonic antigen) that can help detect certain types of cancer.
- Comprehensive Assessment: The package combines cancer-specific markers with a complete blood count, offering a holistic view of health.
Who Should Opt for This Package:
- Women interested in assessing their risk for ovarian or breast cancer through specific tumor markers.
- Individuals with a family history of ovarian or breast cancer who want to monitor their cancer risk.
- Women undergoing cancer treatment who want to monitor the effectiveness of their treatment.
As always, it’s important to interpret the test results with the guidance of a healthcare provider who can provide further insights based on the findings. The Cancer Advance Package- Female offers a focused assessment of cancer-related markers and can be beneficial for women looking for insights into their cancer risk or current condition.